Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,330 | -3,503 | -1,859 | -10,777 | -9,023 |
| Depreciation Amortization | 60 | 44 | 16 | 72 | 56 |
| Other Working Capital | 863 | 1,312 | 688 | 455 | 194 |
| Other Operating Activity | -4,599 | 443 | 204 | 2,189 | 1,958 |
| Operating Cash Flow | $-2,346 | $-1,704 | $-951 | $-8,060 | $-6,814 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 32 | 35 | 16 | 77 | 61 |
| Investing Cash Flow | $32 | $35 | $16 | $77 | $61 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,735 | 1,385 | 800 | 1,350 | 1,000 |
| Debt Repayment | -603 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 2,000 | 1,000 |
| Other Financing Activity | 0 | 0 | 0 | 4,875 | 4,875 |
| Financing Cash Flow | $2,132 | $1,385 | $800 | $8,225 | $6,875 |
| Beginning Cash Position | 315 | 315 | 315 | 74 | 74 |
| End Cash Position | 134 | 30 | 180 | 315 | 195 |
| Net Cash Flow | $-181 | $-285 | $-135 | $241 | $121 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,346 | -1,704 | -951 | -8,060 | -6,814 |
| Free Cash Flow | -2,346 | -1,704 | -951 | -8,060 | -6,814 |